Advertisement
Noticias de Forex
Surf Air Mobility Appoints Oliver Reeves To Succeed Deanna White As New CFO
Air mobility platform Surf Air Mobility Inc. (SRFM) announced Wednesday that Oliver Reeves will join the Company as Chief Financial Officer. Reeves will lead the Company's financial and capital markets strategies leveraging his nearly two decades of experience in the investment management, enterprise technology, and insurance industries.
RTTNews |
hace 600
NKGen Biotech Receives Clearance For SNK01 NK Cell Therapy Clinical Trial From Health Canada
Biotechnology company NKGen Biotech Inc. (NKGN) announced Wednesday that it has received a No Objection Letter from Health Canada for its Clinical Trial Application for a Phase 1/2a study to evaluate the safety, tolerability, and exploratory efficacy of SNK01 natural killer cell therapy for the treatment of patients with moderate Alzheimer's Disease.
RTTNews
|
hace 600
Zevra Therapeutics Resubmits Arimoclomol NDA To FDA
Zevra Therapeutics, Inc. (ZVRA) announced Wednesday it resubmitted its New Drug Application (NDA) for arimoclomol to the U.S. Food and Drug Administration (FDA) on December 22, 2023. Arimoclomol is an investigational therapeutic candidate for the treatment of Niemann-Pick disease type C (NPC).
RTTNews
|
hace 600
Hollysys Automation Says 'Go-Shop' Period Under Merger Deal With Ascendent Capital Ends
Hollysys Automation Technologies Ltd. (HOLI) announced Wednesday the end of the "go-shop" period as provided for in the merger agreement with funds managed by Ascendent Capital Partners.
RTTNews
|
hace 600
FTSE 100 Joins Market Rally Fuelled By Rate Cut Hopes
The FTSE 100 added more than half a percent amidst widespread optimism of an earlier-than-expected rate cut by the Federal Reserve.
RTTNews
|
hace 600
Rate Cut Hopes Propel CAC-40 Higher
The CAC-40 gained tracking European peers as well as Asian and Wall Street markets that traded on a positive note.
RTTNews
|
hace 600
First Wave BioPharma To Sell Niclosamide Program To Undisclosed Biopharmaceutical Company
Biopharmaceutical company First Wave BioPharma, Inc. (FWBI) announced Wednesday that it has entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases (IBD) such as ulcerative colitis and related conditions to an undisclosed biopharmaceutical company.
RTTNews
|
hace 600
more news
DAX Rises As Rate Cut Hopes Strengthen
DAX resumed trading on a positive note after a holiday break. Better-than-expected PCE-based inflation readings from the U.S that bolstered rate cut hopes lifted sentiment at the Frankfurt bourse.
RTTNews
|
hace 600
Asian Markets Track Wall Street Higher
Renewed rate cut optimism amidst easing inflationary pressures in the U.S. lifted Asian stocks on Wednesday.
RTTNews
|
hace 600
Commodity Currencies Climb Amid Risk Appetite
Commodity currencies such as the Australia, the New Zealand and the Canadian dollars strengthened against their major currencies in the Asian session on Wednesday, as Asian shares traded higher amid optimism about the outlook for interest rates following last week's tamer-than-expected U.S. consumer price inflation data. Some traders also kept on the sidelines ahead of a relatively quiet last week of the year.
RTTNews
|
hace 600
European Markets Brace For Positive Opening
Renewed expectations of rate cuts by the Federal Reserve and the positive sentiment in Wall Street on Tuesday is seen helping European markets resume trading on Wednesday on a strong note.
RTTNews
|
hace 600
Canadian Dollar Climbs Against Most Majors
The Canadian dollar strengthened against most major currencies in the Asian session on Wednesday.
RTTNews
|
hace 600
NZ Dollar Advances Against Most Majors
The New Zealand dollar strengthened against most major currencies in the Asian session on Wednesday.
RTTNews
|
hace 600
Stay up to date!
Add Noticias to your browser
Add To Chrome
